In preliminary reports of the application of the indirect fluorescent antibody technique to the detection of serum antibody to Entamoeba histolytica (Jeanes, 1966; Mullan, Ward, Shah, and Jeanes, 1967) it was shown that sera obtained from patients with hepatic amoebiasis were reactive to a titre which clearly distinguished them from the sera of randomly selected patients with diseases or disorders other than amoebiasis. Similar studies have been reported by Goldman (1966) and by Boonpucknavig and Nairn (1967) . The purpose of the present paper is to report the titres obtained in a larger series of cases of intestinal and extraintestinal amoebic infection, and to compare them with the titres obtained in normal subjects, patients with diseases other than amoebiasis, and symptomless carriers of Entamoeba histolytica.
MATERIALS AND METHODS
THE SERA TESTED Samples of serum were obtained during or soon after the acute stage of the disease, from 40 cases of intestinal and 61 cases of extraintestinal amoebic infection. In all cases, the diagnosis was based on the clinical evidence, the results of other investigations, and the response of the patients to antiamoebic therapy.
Control sera were obtained from 128 blood donors living in the London area, 116 donors of African race from the Durban area, and 270 patients attending or admitted to Guy's 14ospital, London, with diseases or disorders other than amoebiasis. The latter group included 38 cases of non-amoebic liver disease and four "The work described in this paper formed part of a thesis approved by the University of London for the degree of M.D. Received for publication 14 November 1968. cases of non-specific ulcerative colitis. In addition, sera were obtained from 37 patients who had no symptoms attributable to amoebic infection, but whose stools were found on routine examination to contain cysts or trophozoites with the characteristics of Entamoeba histolytica.
Finally (Jeanes, 1966 ).
RESULTS
The In four cases of amoebic infection, the titre was less than 1: 32. In one of these, clinically diagnosed as hepatic amoebiasis, serological tests for amoebiasis, including complement-fixation, gel-diffusion, and haemagglutination tests, were reported as negative by all other laboratories participating in an international trial (Dr I. G. Kagan, personal communication, 1966) . In the second case, diagnosed as amoebic empyema, the amoebic gel-diffusion precipitin test was reported to be positive (Dr S. J. Powell, personal communication, 1966 While it is not intended to discuss here technical details at length, it may be said that the outstanding advantage of the fluorescent antibody method is that the tests are read by direct visualization of intact amoebic cells, thus eliminating the risk of false positive results arising from chance reactions of the test serum with impurities in the antigen preparation. The tests are simple to perform, only a single 'drop' of serum is required for a full titration, and the result of a titration may be given less than two hours after receiving the sample in the laboratory.
A disadvantage of the method, as illustrated by the results presented here, is that low-titre reactions are given by a small proportion of normal subjects, and by a rather higher proportion of patients with non-amoebic disorders. It is possible that in some cases, particularly in those from endemic areas, such reactions are due to previous amoebic infection or to the undetected carriage of amoebae in the intestine. The relative distribution of titres in normal British subjects was almost identical, however, with that observed in normal African subjects residing in the Durban area, where amoebiasis is prevalent. It therefore seems likely that the majority of lowtitre reactions given by 'non-amoebic' sera do not result from previous or subclinical amoebic infection.
From the results obtained in this study it is seen that a titre of 1: 32 is suggestive of active amoebic infection, but may also occur in symptomless carriers of Entamoeba histolytica, patients with a history of previous amoebic infection, and, very occasionally, in patients with non-amoebic disease. Titres of 1:64 or above, however, were obtained only in cases of active or recent amoebic infection and could therefore be regarded as 'diagnostic'. Such titres were recorded in 75-0 % of cases of intestinal amoebic infection and in 95-2 % of cases of extraintestinal infection.
The laboratory diagnosis of intestinal amoebiasis depends primarily on the identification of the causative organism in the stools, and to a much lesser extent on serological studies. Since 'diagnostic' titres were obtained in a substantial proportion of cases, however, the fluorescent antibody test might well be of confirmatory value in doubtful cases, and a changing titre could serve as a guide to the effectiveness of therapy. 
